As of January 2025, the intrinsic value of the stock is estimated to be 4,137.50. With the current stock price around 2,445, the stock appears to be approximately 41.0% undervalued, presenting a potential buying opportunity for long-term investors.
However, given the broader market correction, it's possible that the stock may experience further downside before reaching a strong support level. Specifically, the price could test 2,200, which looks like a potential ideal buy zone, followed by 1,924 as a secondary support level.
Despite the potential for further corrections, investors may consider starting to accumulate shares at the current levels. Given the significant undervaluation compared to the intrinsic value, this could position investors well for future gains.
However, given the broader market correction, it's possible that the stock may experience further downside before reaching a strong support level. Specifically, the price could test 2,200, which looks like a potential ideal buy zone, followed by 1,924 as a secondary support level.
Despite the potential for further corrections, investors may consider starting to accumulate shares at the current levels. Given the significant undervaluation compared to the intrinsic value, this could position investors well for future gains.
Do what others don’t know, and don’t do what others know.
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
Do what others don’t know, and don’t do what others know.
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。